NDC properties for "lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel" (RxCUI 2603492)
About this data
The tables show NDC propoerties for lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel with the RxCUI 2603492
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel (RxCUI 2603492)
RxCUI | 2603492 |
---|---|
SPL_SET_ID | 4ef999e7-cdcd-4709-8257-193485e5848b |
Prescribable Synonym | lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel |
RXNAV_STR | lidocaine hydrochloride 0.05 MG/MG / racepinephrine hydrochloride 0.0001 MG/MG / tetracaine hydrochloride 0.01 MG/MG Topical Gel |
RxNorm Name | lidocaine hydrochloride 0.05 MG/MG / racepinephrine hydrochloride 0.0001 MG/MG / tetracaine hydrochloride 0.01 MG/MG Topical Gel |
RxNorm Synonym | lidocaine HCl 5 % / racepinephrine HCl 0.01 % / tetracaine HCl 1 % Topical Gel |
Related queries | Interactions (for RxCUI 2603492) |
NDC Properties
NDC Item 80069001301
NDC 9 | 80069-013 |
---|---|
NDC 10 | 80069-013-01 |
NDC Item | 80069001301 |
Packaging | 28.3495 g in 1 BOTTLE, PLASTIC (80069-013-01) |
FDA SPL set id | 784583 |
Labeler | Dermal Source, Inc. |
Label type | HUMAN OTC DRUG |
Marketing category | OTC MONOGRAPH DRUG |
Marketing effective time high | 2024-11-24 |
Marketing effective time low | 2022-06-07 |
Marketing status | COMPLETED |
OTC_MONOGRAPH_DRUG | M017 |
Related queries | Properties for NDC 9 80069-013 |